Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It's a ...
If you have Microsoft Office, consider Microsoft Excel's suite of budgeting templates designed to fit many different needs, ...
The Medicare GLP-1 Bridge program will cover weight loss drugs for a $50 monthly copay for eligible beneficiaries through Dec. 31, 2027. Medicare currently does not cover GLP-1 drugs for weight loss ...
Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain. Researchers found that people regain weight faster after quitting these ...
The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies. The orforglipron pill, called ...
At the end of a seemingly ubiquitous commercial for telehealth company Ro, a characteristically flabbergasted Charles Barkley speaks for us all when he remarks, “Wait, you’re telling me they have a ...
A new class of weight-loss drug just took a major step toward approval for use. In a phase 3 clinical trial, the medication retatrutide helped control blood sugar levels in participants with type 2 ...
March Madness 2026 is here, and it’s time to lock in your picks on a fresh, printable NCAA Tournament bracket. The men’s tournament field will be revealed on Selection Sunday, March 15, with the First ...
KENT COUNTY, Mich. — A new oral version of the weight loss drug Wegovy has been approved by the FDA, offering a more affordable and accessible alternative to injectable GLP-1 medications that have ...
The 2026 Super Bowl is nearly here in a few days, and you need help with your party with some Super Bowl squares. Super Bowl squares continue to be a thing, and Super Bowl 60 -- between the New ...
When Terra Field started taking Wegovy for weight loss in 2022, she finally understood what satiety truly felt like. “It felt the way I thought my body should have been operating the entire time,” ...